Page 4 - Carlo Rosa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Carlo rosa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Carlo Rosa Today - Breaking & Trending Today

Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year

Italian diagnostics firm DiaSorin forecast weaker 2022 sales and a near 60% plunge in COVID-19 revenue, with the rapid rollout of vaccines likely to bring the pandemic under control and crimp. | December 18, 2021 ....

Carlo Rosa , Mrinmay Dey , Jan Harvey , Devika Syamnath , Giancarlo Navach , Gianluca Semeraro , Intesa Sanpaolo , Luminex Corp , Louise Heavens , Diasorins Pa Stock Exchange , Press Release , Nd Dia It0003492391 ,

QIAGEN N.V.: QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON-TB Gold Plus assay on LIAISON XS

Additional U.S. approval for LIAISON XS platform builds on FDA approval in 2019 for QuantiFERON assay running on DiaSorin's LIAISON XL analyzer Collaboration now provides full range of automation ....

Emanuela Salvini , Thierry Bernard , Carlo Rosa , John Gilardi , Thomas Theuringer , Phoebe Loh , Exchange Commission , Diasorin Group , Italian Stock Exchange , World Health Organization , Drug Administration , Us Securities Exchange , Gamma Release Assay , Frankfurt Prime Standard , Molecular Diagnostics , Applied Testing , Vitro Diagnostic , Life Science , Exchange Act ,

Rosa (DiaSorin): "Mi auguro che sempre più licei aderiscano al progetto Mad for Science"

"Come azienda leader nella ricerca avanzata in campo biomedico, abbiamo deciso di investire nel talento degli insegnanti e delle giovani generazioni, ideando e promuovendo per quattro anni Mad for Science, che ora, alla sua quinta edizione, da progetto di Responsabilità Sociale d’Impresa, è diventato la mission della Fondazione DiaSorin. Mi auguro che, anche grazie all’interlocuzione creatasi con il Ministero dell’Istruzione, sempre più scuole conoscano il progetto e possano coglierne le opportu ....

Ministero Dell Istruzione , Carlo Rosa ,

QIAGEN launches the new LIAISON LymeDetect Assay based on QuantiFERON in partnership with DiaSorin

QIAGEN launches the new LIAISON LymeDetect Assay based on QuantiFERON in partnership with DiaSorin
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

United States , Thierry Bernard , Carlo Rosa , Lyme Borreliosis , Diasorin Group , Product News , Detect Assay , Erythema Migrans , Western Europe , Western Blot , Plus Assay , Chief Executive Officer , Value Based Care , North America , ஒன்றுபட்டது மாநிலங்களில் , தியரி பெர்னார்ட் , கார்லோ ரோசா , ப்ராடக்ட் செய்தி , மேற்கு யூரோப் , மேற்கு கறை , தலைமை நிர்வாகி அதிகாரி , மதிப்பு அடிப்படையிலானது பராமரிப்பு , வடக்கு அமெரிக்கா ,

DiaSorin S p A : , in partnership with QIAGEN, launches the new LIAISON® LymeDetect® Assay based on QuantiFERON technology

Message :
Required fields
DIASORIN, IN PARTNERSHIP WITH QIAGEN, LAUNCHES THE NEW LIAISON® LYMEDETECT® ASSAY BASED ON QUANTIFERON TECHNOLOGY IN COUNTRIES ACCEPTING CE MARK FOR EARLY DIAGNOSIS OF LYME BORRELIOSIS
THE LIAISON® LYMEDETECT® ASSAY IS A SOLUTION FOR THE EARLY DIAGNOSIS OF LYME BORRELIOSIS COMBINING DETECTION OF IGG AND IGM ANTIBODIES AND CELLULAR IMMUNITY
THE TEST IS AVAILABLE IN COUNTRIES ACCEPTING THE CE MARK AND IS DESIGNED TO BE RUN ON
THE LIAISON® XL AND LIAISON® XS PLATFORMS
IN CLINICAL STUDIES, THE ASSAY SHOWED, WITHIN 21 DAYS FROM THE FIRST EVIDENCE OF INFECTION, A SENSITIVITY OF 74% VERSUS THAT OF EXISTING ESTABLISHED METHODS AT 49%, WHILE ALSO DEMONSTRATING A HIGH DIAGNOSTIC SPECIFICITY OF 100% ....

Emanuela Salvini , Thierry Bernard , Carlo Rosa , John Gilardi , Robert Reitze , Thomas Theuringer , Phoebe Makiello , Lyme Borreliosis , Phoebe Loh , Roberta Sykes , Exchange Commission , Diasorin Group , Life Sciences , Italian Stock Exchange , Us Securities Exchange , Frankfurt Prime Standard , Erythema Migrans , Western Europe , Western Blot , Value Based Care , Chief Executive Officer , Plus Assay , Vitro Diagnostic , Molecular Diagnostics , Looking Statement , Exchange Act ,